06
Daewoong Pharma
069620.KQ·KOSDAQSeoul KRFounded 19452,500 employees
Small CappharmaPublicDermatologyGI
Platform: Fexuprazan
Market Cap
$1.5B
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (069620.KQ)
Loading 069620.KQ stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| 069-1659 | 069-1659 | Preclinical | 1 | C5 | Atopic DermMDD | ||
| Olpasertib | 069-3718 | Phase 2 | 2 | MALT1 | RCCCRC |
SEC Filings & Financial Documents
SEC filings are not available for KOSDAQ-listed companies.
Daewoong Pharma trades on KOSDAQ (KR). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (2)